Search results
Gerdau Graphene Launches Certification of Authenticity for Exclusive G2D Technology
Digital Journal· 2 days agoDeveloped exclusively by the company, G2D is a technology for incorporating carbon nanomaterials such as graphene...
Intel Eyes Increased AI Product Demand, Shifts Focus to Private Data Storage Solutions
Benzinga via Yahoo Finance· 6 days agoIntel Corp (NASDAQ:INTC) is gearing up for increased demand for AI-capable consumer products. It...
Hamamatsu Photonics completes the acquisition of NKT Photonics A/S
The Woonsocket Call· 6 days agoHamamatsu Photonics K.K. (Hamamatsu City, Japan) is delighted to announce the completion of the acquisition of NKT Photonics A/S. The Hamamatsu Photonics Group now possesses a very broad range ...
Tech center, retail, housing and more, owner lays out vision for Kenwood Commons
CBS 6 Albany· 6 days agoMore than a year after Doane Stuart School tragically burned to the ground, a new ownership group is...
Gauzy Ltd. (GAUZ) to Raise $75 Million in IPO
ETF DAILY NEWS· 5 days agoGauzy Ltd. (GAUZ) expects to raise $75 million in an initial public offering (IPO) on Thursday, June 6th, IPO Scoop reports. Thecompany will issue...
Why Coherent Shares Are Seeing Blue Skies Today - Coherent (NYSE:COHR)
Benzinga· 3 days agoJim Anderson appointed CEO of Coherent Corp. succeeding retiring CEO Dr. Mattera. Coherent recently launched new laser sensor.
Curiteva Surpasses 1,000 Procedures With Inspire(R) Cervical Trabecular PEEK(TM) With HAFUSE(R)...
Digital Journal· 2 days agoThe first-to-market combination of the HA FUSE nanotechnology surface treatment and novel porous PEEK structure creates a hydrophilic, bioactive environment for cell attachment ...
3 Under-$10 Dividend Stocks to Buy at a Valuation Gap
InvestorPlace· 2 days agoLow-price dividend stocks are among my favorite bets. Of course, the beta of these ideas is not as...
Coming to America: Indian immigrants arrive as students, make their mark in science
St. Louis Post-Dispatch· 5 days agoMeera Chandrasekhar left India in 1975 to study in the United States, driven by her passion for...
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have...
Morningstar· 3 days agoCARDIFF, UK / ACCESSWIRE / June 3, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) just announced promising phase 2 results for its newly in-licensed drug eRapa for treating familial adenomatous ...